Catheter Design Articles & Analysis
24 news found
Among the various materials used in medical device design, polytetrafluoroethylene (PTFE tubing) has emerged as a standout choice, particularly in applications such as catheters and drug delivery systems. ...
Paul was given the opportunity to observe and contribute to the Engineering Team in the development of an innovative new catheter design. This project, slated for future release, provided Paul with invaluable hands-on experience in a dynamic and cross-cultural engineering environment. ...
Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), announced the publication of the results of its Cryocure-2 ultra-low temperature cryoablation (ULTC) study in patients with AF in the Journal of American College of Cardiology (JACC), Clinical Electrophysiology.1 The study prospectively ...
Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, has named Eric S. ...
The Shockwave M5+ catheter, which has been in limited launch until today, is specifically designed to decrease IVL treatment time, provide alternative access options, and expand IVL therapy to patients with larger vessel sizes. “Shockwave’s new peripheral catheter offers remarkable improvements that enable efficient and effective ...
The inception of this study highlights Acutus’ unique therapeutic position offering the first and only force sensing gold-tip ablation catheter, AcQBlate Force, designed to deliver either radiofrequency (RF) or PFA therapy – with the added benefit of fully integrating with therapy guidance provided by the novel AcQMap 3D Imaging and Mapping System. ...
This prospective, multi-center clinical trial is the first study designed to evaluate the clinical benefits of direct aspiration for the treatment of ischemic stroke with the Zoom 88 Large Distal Platform, which is currently FDA cleared for neurovascular access. ...
Armadillo is a radial platform of access catheters specifically designed to address the needs and challenges of radial access. ...
“The system leverages our unique iCLAS™ platform technology for the ablation of atrial arrythmias which is commercially available in Europe and is undergoing FDA IDE trial in the US. The VT catheter is designed to meet stringent anatomic and physiologic requirements of ventricular ...
Instead, the locators clip onto the patient’s native anatomy to provide valve security. The valve’s unique design also enables anatomical valve alignment, which facilitates future access to the coronary arteries and beneficial hemodynamics, both of which are significant clinical advantages for the treatment of aortic regurgitation and aortic stenosis. ...
The following products will join the Vascular portfolio: Makoto Intravascular Imaging System, the only FDA-cleared dual-modality catheter and imaging system indicated for the detection of lipid core plaque (LCP) and the identification of plaque and patients at higher risk of MACE, from Infraredx, a Nipro company. Dualpro IVUS+NIRS Imaging Catheter, a ...
JenaValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA), which allows for priority review of the ALIGN Clinical Trial for the treatment of symptomatic, severe aortic regurgitation (AR) and AR-dominant mixed aortic valve disease.JenaValve’s TAVR System is differentiated in that no other transcatheter valve device is currently ...
Food and Drug Administration (FDA) for its family of access catheters designed to facilitate smooth, consistent navigation into blood vessels of the brain. The company has also received FDA clearance for its ZOOM Aspiration System, a family of products designed to facilitate clot removal during ischemic stroke. Stroke remains a largely ...
The ZOOM Reperfusion Catheters are designed with the TRX™ tip to navigate complex anatomy and optimally engage blood clots. The ZOOM Reperfusion Catheters come in four sizes (.071”, .055”, .045”, and .035” Internal Diameter) and are designed to enable smooth tracking through challenging vasculature. ...
Food and Drug Administration (FDA) 510(k) clearance of its first family of access catheters, designed to deliver interventional treatments during minimally invasive neurovascular procedures for aneurysms, stroke and other brain blood vessel conditions. ...
The recently FDA-approved Ellipsys System is a minimally-invasive, single catheter-based system designed for ESRD patients requiring hemodialysis. ...
Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, announced today it has hired three additional team members to support the advancement of its intra-aortic heart pump, AortixTM, for use in NYHA Class III-IV heart failure patients. ...
Procyrion, Inc., a medical device company developing a catheter-deployed micropump for the management of chronic heart failure, today announced that its AortixTM device won the MedTech Breakthrough Award for "Best Overall Medical Device Product." ...
The FDA 510(k) clearance and EU approval of the Alivio ReFlow™ Ventricular System permits Anuncia to commercialize the innovative technology for treatment of hydrocephalus in the US, and Europe, to provide qualified clinicians with the option of non-invasive retrograde flushing of the ventricular catheter, to unblock occluded inlet holes or open a relief membrane to restore ...
The FDA 510(k) clearance and EU approval of the ReFlow Ventricular System permits Anuncia to commercialize the innovative technology for treatment of hydrocephalus in the US, and Europe, to provide qualified clinicians with the option of non-invasive retrograde flushing of the ventricular catheter, to unblock occluded inlet holes or open a relief membrane to restore or increase ...